Recombinant proteins are an indispensable tool in drug discovery. The need for multiple forms of recombinant proteins, e.g. wild/mutant/fusion, from different species is increasing and […]
Mass spectrometry (MS) has become an important tool for high-throughput screening, owing to its ability to directly probe interactions between target proteins and ligands from […]
New Technology Department was established as a natural expansion of Bienta and currently provides services for Recombinant Proteins Production and Screening by Mass Spectrometry.
The Screening Group provides hit identification and hit-to-lead optimization contract services to the biotech and pharmaceutical industry. We are also open to discuss shared-risk exploratory […]
The growing Bienta currently employs 83 FTEs and is capable of performing HTS with a broad variety of biochemical and cell-based assays.
Our Molecular Modeling group provides cheminformatics, molecular modeling, virtual screening and computational biology services aiming to accelerate hit identification, lead generation and lead optimization stages […]